# FDA recall D-0507-2024

> **American Regent, Inc.** · Class II · drug recall initiated 2024-05-13.

## Product

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only,  For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

## Reason for recall

Subpotent product in addition to having out-of-specification results for impurities.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0507-2024
- **Recalling firm:** American Regent, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-05-13
- **Report date:** 2024-05-29
- **Termination date:** 2025-12-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New Albany, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0507-2024

## Citation

> AI Analytics. FDA recall D-0507-2024. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0507-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*